Associate Research Fellow Pfizer Research and Development Groton, Connecticut, United States
Impurity and degradation product understanding and control strategies are a fundamental piece of the drug development process. Understanding the impurity qualification process from what animal models are used through how the resulting data may be used to support impurity limits will form an essential knowledge base for attendees. Best practices in impurity qualification based on industry experience will be discussed.
